Literature DB >> 17510153

Genital herpes and its management.

P Sen1, S E Barton.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17510153      PMCID: PMC1871807          DOI: 10.1136/bmj.39189.504306.55

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  16 in total

Review 1.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

2.  Acyclovir prophylaxis for pregnant women with a known history of herpes simplex virus: a cost-effectiveness analysis.

Authors:  Sarah E Little; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

3.  Incidence of genital herpes simplex virus at the time of delivery in women with known risk factors.

Authors:  P M Catalano; A O Merritt; P B Mead
Journal:  Am J Obstet Gynecol       Date:  1991-05       Impact factor: 8.661

4.  Reducing the transmission of genital herpes.

Authors:  Simon E Barton
Journal:  BMJ       Date:  2005-01-22

5.  HIV and other sexually transmitted infections in the United Kingdom: an update 2005.

Authors:  Leah de Souza-Thomas; Sarah Dougan; Lynsey Emmett; Laura James
Journal:  Euro Surveill       Date:  2005-12-22

6.  Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis.

Authors:  Anna Wald; Katherine Link
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

7.  Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group.

Authors:  K H Fife; R A Barbarash; T Rudolph; B Degregorio; R Roth
Journal:  Sex Transm Dis       Date:  1997-09       Impact factor: 2.830

8.  Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.

Authors:  R Patel; N J Bodsworth; P Woolley; B Peters; G Vejlsgaard; S Saari; A Gibb; J Robinson
Journal:  Genitourin Med       Date:  1997-04

9.  Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection.

Authors:  R Patel; S Tyring; A Strand; M J Price; D M Grant
Journal:  Sex Transm Infect       Date:  1999-12       Impact factor: 3.519

10.  Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial.

Authors:  G J Mertz; C C Jones; J Mills; K H Fife; S M Lemon; J T Stapleton; E L Hill; L G Davis
Journal:  JAMA       Date:  1988-07-08       Impact factor: 56.272

View more
  4 in total

1.  A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease.

Authors:  Dirk Bauer; Mira Alt; Miriam Dirks; Anna Buch; Christiane S Heilingloh; Ulf Dittmer; Bernd Giebel; André Görgens; Vivien Palapys; Maren Kasper; Anna M Eis-Hübinger; Beate Sodeik; Arnd Heiligenhaus; Michael Roggendorf; Adalbert Krawczyk
Journal:  Front Microbiol       Date:  2017-10-31       Impact factor: 5.640

2.  Human gene and disease associations for clinical-genomics and precision medicine research.

Authors:  Zeeshan Ahmed; Saman Zeeshan; Dinesh Mendhe; XinQi Dong
Journal:  Clin Transl Med       Date:  2020-01

3.  First description of herpes simplex virus type 1 epididymo-orchitis: A new clinical form of herpes simplex virus infection during septic shock?

Authors:  Dr Mélanie Fromentin; Remy Gauzit; Benoit Gille; Charles Marc Samama
Journal:  IDCases       Date:  2016-09-15

4.  Assessment of Two Novel Live-Attenuated Vaccine Candidates for Herpes Simplex Virus 2 (HSV-2) in Guinea Pigs.

Authors:  Jonathan D Joyce; Anant K Patel; Brandie Murphy; Daniel J J Carr; Edward Gershburg; Andrea S Bertke
Journal:  Vaccines (Basel)       Date:  2021-03-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.